PT97082A - Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos - Google Patents

Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos

Info

Publication number
PT97082A
PT97082A PT97082A PT9708291A PT97082A PT 97082 A PT97082 A PT 97082A PT 97082 A PT97082 A PT 97082A PT 9708291 A PT9708291 A PT 9708291A PT 97082 A PT97082 A PT 97082A
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
agents
agressoes
useful
preparation
Prior art date
Application number
PT97082A
Other languages
English (en)
Other versions
PT97082B (pt
Inventor
Jerome Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT97082A publication Critical patent/PT97082A/pt
Publication of PT97082B publication Critical patent/PT97082B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT97082A 1990-03-21 1991-03-20 Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos PT97082B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21

Publications (2)

Publication Number Publication Date
PT97082A true PT97082A (pt) 1991-11-29
PT97082B PT97082B (pt) 1998-07-31

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97082A PT97082B (pt) 1990-03-21 1991-03-20 Processo para a preparacao de uma composicao farmaceutica contendo il-4,util para aumentar a resposta imunitaria a agressoes de antigenios infecciosos

Country Status (19)

Country Link
EP (1) EP0521916B1 (pt)
JP (1) JPH05505799A (pt)
CN (1) CN1055116A (pt)
AT (1) ATE133074T1 (pt)
AU (1) AU656889B2 (pt)
CA (1) CA2078676A1 (pt)
DE (1) DE69116552T2 (pt)
DK (1) DK0521916T3 (pt)
ES (1) ES2082201T3 (pt)
FI (1) FI924215L (pt)
GR (1) GR3019018T3 (pt)
HU (1) HUT63062A (pt)
IE (1) IE72204B1 (pt)
IL (1) IL97600A0 (pt)
MY (1) MY108672A (pt)
OA (1) OA09672A (pt)
PT (1) PT97082B (pt)
WO (1) WO1991014450A1 (pt)
ZA (1) ZA912037B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
DK0563254T3 (da) * 1990-12-19 1996-02-12 Schering Corp Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
JPH0747545B2 (ja) * 1991-01-10 1995-05-24 シェリング・コーポレーション 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
CA2142862C (en) * 1992-08-19 2000-05-30 Jerome Schwartz Method for inhibiting hiv replication using il-4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
ES2059453T3 (es) * 1987-08-03 1994-11-16 Tasuku Honjo Un procedimiento para la produccion de interleuquina 4 humana.
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解

Also Published As

Publication number Publication date
DE69116552T2 (de) 1996-05-30
WO1991014450A1 (en) 1991-10-03
EP0521916A1 (en) 1993-01-13
CA2078676A1 (en) 1991-09-22
ES2082201T3 (es) 1996-03-16
AU7469091A (en) 1991-10-21
IE72204B1 (en) 1997-04-09
OA09672A (en) 1993-05-15
FI924215A0 (fi) 1992-09-21
FI924215A7 (fi) 1992-09-21
IE910921A1 (en) 1991-09-25
CN1055116A (zh) 1991-10-09
GR3019018T3 (en) 1996-05-31
AU656889B2 (en) 1995-02-23
FI924215L (fi) 1992-09-21
DK0521916T3 (da) 1996-03-04
DE69116552D1 (de) 1996-02-29
JPH05505799A (ja) 1993-08-26
PT97082B (pt) 1998-07-31
ZA912037B (en) 1992-03-25
EP0521916B1 (en) 1996-01-17
HUT63062A (en) 1993-07-28
MY108672A (en) 1996-10-31
ATE133074T1 (de) 1996-02-15
IL97600A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
BR9106977A (pt) Metodo para suprimir destruicao autoimune de celuias beta pancreaticas,formulacao farmaceutica,metodo de profilaxia,metodo para prevenir o surgimento de diabetes tipo 1 e metodo para tratar um mamifero
BR9909915A (pt) Composições adjuvantes
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
DE69729887D1 (de) Purin-l-nukleoside, deren analoga und verwendungen
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
DK0563254T3 (da) Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
IL97600A0 (en) Use of il-4 to enhance immune response to infectious antigenic challenges
DK0542860T3 (da) Immunosuppressive sammensætninger
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
ATE229981T1 (de) Glykolisierte cytokine
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
Playfair Recent developments in the assessment of the immune response to malaria, especially as related to vaccination: Lethal Plasmodium yoelii malaria: the role of macrophages in normal and immunized mice
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
FI981624A0 (fi) Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi
IT8948600A0 (it) Composizione per la profilassi anticarie dello smalto umano
ITRM910038A1 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.
IT1229519B (it) Composizione farmaceutica comprendente come ingrediente attivo 3-(n-piperidinometil- azino) metilrifamicina s

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910724

FG3A Patent granted, date of granting

Effective date: 19980417

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20011031